STOCK TITAN

Inspire Medical Systems, Inc. to Present at the Piper Sandler 38th Annual Healthcare Conference

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Inspire Medical Systems (NYSE: INSP) will present at the Piper Sandler 38th Annual Healthcare Conference on December 1, 2026. Management’s presentation is scheduled for 3:00 p.m. Eastern Time and will be webcast live. A replay will be available for two weeks afterward in the Event Archive section of Inspire’s investor website.

Loading...
Loading translation...

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MINNEAPOLIS, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Piper Sandler 38th Annual Healthcare Conference on Tuesday, December 1, 2026.

Inspire is scheduled to present at 3:00 p.m. Eastern Time. The presentation will be accessible via a live webcast here.

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor Contact
Brian Johnston or Louisa Smith
Gilmartin Group, LLC
IR@inspiresleep.com


Keep reading